Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers
Completed · Not applicable
Conditions studied: Cystic Fibrosis
In brief
Inflammation clearly contributes to the progression of the cystic fibrosis (CF) lung disease, and administration of the anti-inflammatory agent high-dose ibuprofen retards the rate of decline of pulmonary function. However, utilization of this valuable drug has been suboptimal because of its rare, but dramatic, adverse effects. Therefore, alternative anti-inflammatory agents are urgently needed. One strategy for identifying new anti-inflammatory agents is to determine the mechanism by which the only proven anti-inflammatory agent for the CF lung disease, high-dose ibuprofen, exerts its effect. If this were known, then other drugs that act by a similar mechanism become candidates for treating the CF inflammatory disease. The investigators have shown, in our preliminary studies, that high dose ibuprofen limits the delivery of neutrophils to an inflamed mucosal surface, the gingival crevices. The investigators plan to test pioglitazone and simvastatin, (ibuprofen (positive control)) to determine their anti inflammatory affects on neutrophil migration to the oral mucosa. The hypothesis to be tested is that pioglitazone, and/or simvastatin will reduce neutrophils in the oral mucosa after 10 days of therapy in mouthwashes of healthy volunteers. Ibuprofen will be used as a positive control. This study will provide pilot data from healthy volunteers to support an FDA Grant to be submitted at a future date.
Key facts
- Study ID
- NCT00531882
- Run by
- University Hospitals Cleveland Medical Center
- People needed
- 25
- Starts
- 2007-09-01
- Expected to finish
- 2009-02-01
- Last updated by the study team
- 2017-10-05
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- ≥ 18 < 50 years of age
- Healthy volunteers must be in general good health as determined by a medical history.
- Ability to understand and sign the informed consent form
- Ability to adhere to the protocol.
- Willing to use an acceptable form of birth control
You may not qualify if…
- History of diabetes requiring insulin
- The use of NSAIDS (ibuprofen) or corticosteroids including inhaled steroids. Nasal steroids are acceptable.
- The use of statin lowering medications
- Active gingival disease (Active tooth or gum disease)
- Any chronic inflammatory condition that immuno compromises the volunteer as determined by medical history.
- Pregnant or planning to become pregnant
Where it is running
- Rainbow Babies and Children's Hospital — Cleveland, Ohio, United States
- University Hospitals of Cleveland — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.